Aligos Therapeutics, Inc. Shares Outstanding (Cover Page)
Aligos Therapeutics, Inc. (ALGS) had Shares Outstanding (Cover Page) of 42.61 million shares as of 2021-08-04, per its 10-Q filed 2021-08-05.
Discontinued › Notes
dei:EntityCommonStockSharesOutstanding · last filed 2021-08-05
- 2021-08-04: Entity Common Stock, Shares Outstanding 42.61M shares.
- 2021-05-07: Entity Common Stock, Shares Outstanding 38.15M shares.
- 2021-03-18: Entity Common Stock, Shares Outstanding 38.14M shares.
- 2020-11-25: Entity Common Stock, Shares Outstanding 38.12M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2021-08-04 | 42.61M shares 10-Q · filed 2021-08-05 |
| 2021-05-07 | 38.15M shares 10-Q · filed 2021-05-10 |
| 2021-03-18 | 38.14M shares 10-K · filed 2021-03-23 |
| 2020-11-25 | 38.12M shares 10-Q · filed 2020-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |